Metabolic influence on macrophage polarization and pathogenesis

키워드

참고문헌 (142)

1. Cohn ZA, "The Differentiation of Mononuclear Phagocytes. Morphology, Cytochemistry, and Biochemistry", J Exp Med, 121, pp.153~170 (1965)
2. Rouzer CA, "Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes", J Exp Med, 156, pp.1077~1086 (1982)
3. Poltorak A, "Defective LPS signaling in C3H", HeJ and C57BL, Science, pp.1998, 282[DOI]
4. Takeda K, "Toll-like receptors", Annu Rev Immunol, 21, pp.335~376 (2003)
5. Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)
6. Witting A, "Phagocytic clearance of apoptotic neurons by Microglia", Brain macrophages in vitro : involvement of lectin-, integrin-, and phosphatidylserinemediated recognition, 2000, pp.75, 1060~1070
7. Teitelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
8. van Iwaarden JF, "Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways", Am J Respir Cell Mol Biol, 24, pp.452~458 (2001)
9. Willekens FL, "Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors", Blood, 105, pp.2141~2145 (2005)
10. Leibovich SJ, "The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum", Am J Pathol, 78, pp.71~100 (1975)
11. Polverini PJ, "Activated macrophages induce vascular proliferation", Nature, 269, pp.804~806 (1977)
12. Hunt TK, "Studies on inflammation and wound healing : angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages", Surgery, 96, pp.48~54 (1984)
13. Koh TJ, "Inflammation and wound healing : the role of the macrophage", Expert Rev Mol Med, 13, pp.e23~ (2011)
14. Alliot F, "Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain", Brain Res Dev Brain Res, 117, pp.145~152 (1999)
15. Naito M, "Development, differentiation, and maturation of Kupffer cells", Microsc Res Tech, 39, pp.350~364 (1997)
16. Guilliams M, "Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF", J Exp Med, 210, pp.1977~1992 (2013)
17. Ginhoux F, "Tissue-Resident Macrophage Ontogeny and Homeostasis", Immunity, 44, pp.439~449 (2016)
18. Matute-Bello G, "Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice", J Immunol Methods, 292, pp.25~34 (2004)
19. Scott CL, "Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells", Nat Commun, 7, pp.10321~ (2016)
20. Chang CH, "Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression", Cell, 162, pp.1229~1241 (2015)
21. Westendorf AM, "Hypoxia Enhances Immunosuppression by Inhibiting CD4+ Effector T Cell Function and Promoting Treg Activity", Cell Physiol Biochem, 41, pp.1271~1284 (2017)
22. Clambey ET, "Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa", Proc Natl Acad Sci U S A, 109, pp.E2784~2793 (2012)
23. Bantug GR, "The spectrum of T cell metabolism in health and disease", Nat Rev Immunol, 18, pp.19~34 (2018)
24. Mackaness GB, "Cellular resistance to infection", J Exp Med, 116, pp.381~406 (1962)
25. Mosser DM, "Exploring the full spectrum of macrophage activation", Nat Rev Immunol, 8, pp.958~969 (2008)
26. Sica A, "Macrophage plasticity and polarization : in vivo veritas", J Clin Invest, 122, pp.787~795 (2012)
27. Stein M, "Interleukin 4 potently enhances murine macrophage mannose receptor activity : a marker of alternative immunologic macrophage activation", J Exp Med, 176, pp.287~292 (1992)
28. Gordon S, "Alternative activation of macrophages : mechanism and functions", Immunity, 32, pp.593~604 (2010)
29. Wynn TA, "Macrophages in Tissue Repair, Regeneration, and Fibrosis", Immunity, 44, pp.450~462 (2016)
30. Rath M, "Metabolism via Arginase or Nitric Oxide Synthase : Two Competing Arginine Pathways in Macrophages", Front Immunol, 5, pp.532~ (2014)
31. Mills CD, "M-1", M-2 macrophages and the Th1, J Immunol, pp.2000, 164[DOI]
32. Murray PJ, "Macrophage activation and polarization : nomenclature and experimental guidelines", Immunity, 41, pp.14~20 (2014)
33. Qian BZ, "Macrophage diversity enhances tumor progression and metastasis", Cell, 141, pp.39~51 (2010)
34. Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization", Trends Immunol, 25, pp.677~686 (2004)
35. Roszer T, "Understanding the Mysterious M2Macrophage through Activation Markers and Effector Mechanisms", Mediators Inflamm, 2015, pp.816460~ (2015)
36. Pearce EL, "Metabolism in T cell activation and differentiation", Curr Opin Immunol, 22, pp.314~320 (2010)
37. Buck MD, "T cell metabolism drives immunity", J Exp Med, 212, pp.1345~1360 (2015)
38. O'Sullivan D, "Memory CD8(+)T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development", Immunity, 41, pp.75~88 (2014)
39. Slack M, "T cell metabolic reprogramming and plasticity", Mol Immunol, 68, pp.507~512 (2015)
40. Wang T, "HIF1alpha-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages", Mediators Inflamm, 2017, pp.9029327~ (2017)
41. Freemerman AJ, "Metabolic reprogramming of macrophages : glucose transporter 1(GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype", J Biol Chem, 289, pp.7884~7896 (2014)
42. Shirai T, "The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease", J Exp Med, 213, pp.337~354 (2016)
43. Semba H, "HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity", Nat Commun, 7, pp.11635~ (2016)
44. Geeraerts X, "Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity", Front Immunol, 8, pp.289~ (2017)
45. Ryan DG, "Krebs cycle rewired for macrophage and dendritic cell effector functions", FEBS Lett, 591, pp.2992~3006 (2017)
46. Williams NC, "A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation", Front Immunol, 9, pp.141~ (2018)
47. Infantino V, "The mitochondrial citrate carrier : a new player in inflammation", Biochem J, 438, pp.433~436 (2011)
48. Everts B, "Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells", Blood, 120, pp.1422~1431 (2012)
49. Van den Bossche J, "Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages", Cell Rep, 17, pp.684~696 (2016)
50. Michelucci A, "Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production", Proc Natl Acad Sci U S A, 110, pp.7820~7825 (2013)
51. Cordes T, "Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels", J Biol Chem, 291, pp.14274~14284 (2016)
52. Lampropoulou V, "Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation", Cell Metab, 24, pp.158~166 (2016)
53. Tannahill GM, "Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha", Nature, 496, pp.238~242 (2013)
54. Eggleston LV, "Regulation of the pentose phosphate cycle", Biochem J, 138, pp.425~435 (1974)
55. Everts B, "TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation", Nat Immunol, 15, pp.323~332 (2014)
56. Koo SJ, "Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages", Front Immunol, 9, pp.202~ (2018)
57. Haschemi A, "The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism", Cell Metab, 15, pp.813~826 (2012)
58. Baardman J, "A Defective Pentose Phosphate Pathway Reduces Inflammatory Macrophage Responses during Hypercholesterolemia", Cell Rep, 25, pp.2044~2052 (2018)[DOI]
59. Galvan-Pena S, "Metabolic reprograming in macrophage polarization", Front Immunol, 5, pp.420~ (2014)
60. Clementi E, "Persistent inhibition of cell respiration by nitric oxide : crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione", Proc Natl Acad Sci U S A, 95, pp.7631~7636 (1998)
61. Heming M, "Peroxisome Proliferator-Activated Receptor-gamma Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids", Front Immunol, 9, pp.893~ (2018)
62. Lee JH, "SREBP-1astimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4-directed mTORC1", Proc Natl Acad Sci U S A, 115, pp.E12228~E12234 (2018)[DOI]
63. Horton JD, "SREBPs : activators of the complete program of cholesterol and fatty acid synthesis in the liver", J Clin Invest, 109, pp.1125~1131 (2002)
64. Im SS, "Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a", Cell Metab, 13, pp.540~549 (2011)
65. Schneider JG, "Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis", J Biol Chem, 285, pp.23398~23409 (2010)
66. Vats D, "Oxidative metabolism and PGC-1beta attenuate macrophagemediated inflammation", Cell Metab, 4, pp.13~24 (2006)
67. Huang SC, "Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages", Nat Immunol, 15, pp.846~855 (2014)
68. Malandrino MI, "Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation", Am J Physiol Endocrinol Metab, 308, pp.E756~E769 (2015)
69. Nomura M, "Fatty acid oxidation in macrophage polarization", Nat Immunol, 17, pp.216~217 (2016)
70. Namgaladze D, "Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization", Biochim Biophys Acta, 1841, pp.1329~1335 (2014)
71. Huang SC, "Metabolic Reprogramming Mediated by the mTORC2-IRF4Signaling Axis Is Essential for Macrophage Alternative Activation", Immunity, 45, pp.817~830 (2016)
72. Covarrubias AJ, "Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation", Elife, 5, pp.e11612~ (2016)
73. Wang F, "Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation", Cell Metab, 28, pp.463~475 (2018)[DOI]
74. Yang C, "Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport", Mol Cell, 56, pp.414~424 (2014)
75. Wise DR, "Glutamine addiction : a new therapeutic target in cancer", Trends Biochem Sci, 35, pp.427~433 (2010)
76. Ligthart-Melis GC, "Glutamine is an important precursor for de novo synthesis of arginine in humans", Am J Clin Nutr, 87, pp.1282~1289 (2008)
77. Palmieri EM, "Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis", Cell Rep, 20, pp.1654~1666 (2017)
78. Mori M, "Arginine metabolic enzymes, nitric oxide and infection", J Nutr, 134, pp.2820S~2825S (2004)[DOI]
79. Benoit M, "Macrophage polarization in bacterial infections", J Immunol, 181, pp.3733~3739 (2008)
80. Nardin A, "Macrophages and cancer", Front Biosci, 13, pp.3494~3505 (2008)
81. Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance", J Clin Invest, 95, pp.2409~2415 (1995)
82. Schreyer SA, "Obesity and diabetes in TNF-alpha receptor-deficient mice", J Clin Invest, 102, pp.402~411 (1998)
83. Gonzalez-Gay MA, "Insulin resistance in rheumatoid arthritis : the impact of the anti-TNF-alpha therapy", Ann N Y Acad Sci, 1193, pp.153~159 (2010)
84. Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J Clin Invest, 117, pp.175~184 (2007)
85. Pirzgalska RM, "Macrophages in obesity", Cell Immunol, 330, pp.183~187 (2018)
86. Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
87. Frikke-Schmidt H, "Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice", Mol Metab, 6, pp.317~326 (2017)
88. Vandanmagsar B, "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance", Nat Med, 17, pp.179~188 (2011)
89. Meier CA, "IL-1 receptor antagonist serum levels are increased in human obesity:a possible link to the resistance to leptin?", J Clin Endocrinol Metab, 87, pp.1184~1188 (2002)
90. Spranger J, "Inflammatory cytokines and the risk to develop type 2 diabetes : results of the prospective population-based European Prospective Investigation into Cancer and Nutrition(EPIC)-Potsdam Study", Diabetes, 52, pp.812~817 (2003)
91. Sauter NS, "The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia", Endocrinology, 149, pp.2208~2218 (2008)
92. Thomas D, "Macrophage functions in lean and obese adipose tissue", Metabolism, 72, pp.120~143 (2017)
93. Ricardo-Gonzalez RR, "IL-4", STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity, 2010, pp.107, 22617~22622
94. Lesna IK, "Human adipose tissue accumulation is associated with pro-inflammatory changes in subcutaneous rather than visceral adipose tissue", Nutr Diabetes, 7, pp.e264~ (2017)
95. Boutens L, "Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses", Diabetologia, 61, pp.942~953 (2018)
96. Johnson AR, "Metabolic reprogramming through fatty acid transport protein 1(FATP1)regulates macrophage inflammatory potential and adipose inflammation", Mol Metab, 5, pp.506~526 (2016)
97. Shapiro H, "Adipose tissue foam cells are present in human obesity", J Clin Endocrinol Metab, 98, pp.1173~1181 (2013)
98. Rogero MM, "Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids", Nutrients, 10, pp.432~ (2018)
99. Xu X, "Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation", Cell Metab, 18, pp.816~830 (2013)
100. Hick RW, "Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharideinduced thymic atrophy", J Immunol, 177, pp.169~176 (2006)
101. Fernandez-Riejos P, "Role of leptin in the activation of immune cells", Mediators Inflamm, 2010, pp.568343~ (2010)
102. Sheng T, "Adiponectin and its association with insulin resistance and type 2 diabetes", J Genet Genomics, 35, pp.321~326 (2008)
103. Ajuwon KM, "Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6production and increases PPARgamma2 expression in adipocytes", Am J Physiol Regul Integr Comp Physiol, 288, pp.R1220~R1225 (2005)
104. Ohashi K, "Adiponectin promotes macrophage polarization toward an antiinflammatory phenotype", J Biol Chem, 285, pp.6153~6160 (2010)
105. Tsatsanis C, "Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli", Biochem Biophys Res Commun, 335, pp.1254~1263 (2005)
106. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
107. Chen W, "Emerging role of FDG-PET", CT in assessing atherosclerosis in large arteries, 2009, pp.36, 144~151
108. Folco EJ, "Hypoxia but not inflammation augments glucose uptake in human macrophages : Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography", J Am Coll Cardiol, 58, pp.603~614 (2011)
109. Sarrazy V, "Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-", -)Mice, 2016, pp.118, 1062~1077
110. Chait A, "Diabetes and atherosclerosis: is there a role for hyperglycemia?", J Lipid Res, 50, pp.S335~S339 (2009)
111. Nagareddy PR, "Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis", Cell Metab, 17, pp.695~708 (2013)
112. Terasaki M, "Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice", PLoS One, 10, pp.e0143396~ (2015)
113. Nishizawa T, "Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis", Cell Rep, 7, pp.356~365 (2014)
114. Yang X, "Oxidative Stress-Mediated Atherosclerosis : Mechanisms and Therapies", Front Physiol, 8, pp.600~ (2017)
115. Wang Y, "Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kappaB-mediated inflammation in macrophages", Circ Res, 114, pp.421~433 (2014)
116. Cardilo-Reis L, "Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype", EMBO Mol Med, 4, pp.1072~1086 (2012)
117. Wang Y, "Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice", Arterioscler Thromb Vasc Biol, 37, pp.e99~e107 (2017)[DOI]
118. Vink A, "HIF-1alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages", Atherosclerosis, 195, pp.e69~e75 (2007)
119. Aarup A, "Hypoxia-Inducible Factor-1alpha Expression in Macrophages Promotes Development of Atherosclerosis", Arterioscler Thromb Vasc Biol, 36, pp.1782~1790 (2016)
120. Zhang QW, "Prognostic significance of tumor-associated macrophages in solid tumor : a meta-analysis of the literature", PLoS One, 7, pp.e50946~ (2012)
121. Argyle D, "Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors", Front Immunol, 9, pp.2629~ (2018)
122. Chanmee T, "Tumor-associated macrophages as major players in the tumor microenvironment", Cancers (Basel), 6, pp.1670~1690 (2014)
123. Lin EY, "Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy", J Exp Med, 193, pp.727~740 (2001)
124. Quatromoni JG, "Tumor-associated macrophages : function, phenotype, and link to prognosis in human lung cancer", Am J Transl Res, 4, pp.376~389 (2012)
125. Liberti MV, "The Warburg Effect:How Does it Benefit Cancer Cells?", Trends Biochem Sci, 41, pp.211~218 (2016)
126. Romero-Garcia S, "Lactate Contribution to the Tumor Microenvironment : Mechanisms, Effects on Immune Cells and Therapeutic Relevance", Front Immunol, 7, pp.52~ (2016)
127. Penny HL, "Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma", Oncoimmunology, 5, pp.e1191731~ (2016)
128. Wenes M, "Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis", Cell Metab, 24, pp.701~715 (2016)
129. Movahedi K, "Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high)monocytes", Cancer Res, 70, pp.5728~5739 (2010)
130. Park JE, "Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNAmediated metabolic shift", Oncogene (2019)
131. Pyonteck SM, "CSF-1R inhibition alters macrophage polarization and blocks glioma progression", Nat Med, 19, pp.1264~1272 (2013)
132. Casazza A, "Impeding macrophage entry into hypoxic tumor areas by Sema3A", Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity, 2013, pp.24, 695~709
133. Ouimet M, "MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis", J Clin Invest, 125, pp.4334~4348 (2015)
134. Liu M, "Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal", Nat Immunol, 20, pp.265~275 (2019)
135. Miller AM, "Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice", Circ Res, 107, pp.650~658 (2010)
136. Rombaldova M, "Omega-3 fatty acids promote fatty acid utilization and production of pro-resolving lipid mediators in alternatively activated adipose tissue macrophages", Biochem Biophys Res Commun, 490, pp.1080~1085 (2017)
137. Furukawa S, "Increased oxidative stress in obesity and its impact on metabolic syndrome", J Clin Invest, 114, pp.1752~1761 (2004)
138. Xu J, "NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation", J Clin Invest, 125, pp.1579~1590 (2015)
139. Jung MJ, "Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice", Sci Rep, 6, pp.30887~ (2016)
140. Spann NJ, "Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses", Cell, 151, pp.138~152 (2012)
141. Deng J, "Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming", J Immunol, 198, pp.170~183 (2017)
142. Liao X, "Macrophage autophagy plays a protective role in advanced atherosclerosis", Cell Metab, 15, pp.545~553 (2012)

관련 논문AI추천